Cargando…
Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity
Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract disease in children <2 years of age. Increased morbidity and mortality have been reported in high-risk patients, such as premature infants, patients with cardiac disease, and severely immune compromised patients...
Autores principales: | Hijano, Diego R., Vu, Luan D., Kauvar, Lawrence M., Tripp, Ralph A., Polack, Fernando P., Cormier, Stephania A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443902/ https://www.ncbi.nlm.nih.gov/pubmed/30972063 http://dx.doi.org/10.3389/fimmu.2019.00566 |
Ejemplares similares
-
Type I Interferon Potentiates IgA Immunity to Respiratory Syncytial Virus Infection During Infancy
por: Hijano, Diego R., et al.
Publicado: (2018) -
Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein
por: Bergeron, Harrison C., et al.
Publicado: (2023) -
Pathobiology of Respiratory Syncytial Virus (RSV)
por: Tripp, Ralph A., et al.
Publicado: (2020) -
Determining Immune and miRNA Biomarkers Related to Respiratory Syncytial Virus (RSV) Vaccine Types
por: Atherton, Lydia J., et al.
Publicado: (2019) -
Anti-G protein antibodies targeting the RSV G protein CX3C chemokine region improve the interferon response
por: Bergeron, Harrison C., et al.
Publicado: (2023)